Medicine

High court weighs generic drugmaker liability

High court weighs generic drugmaker liability

Published 19/03/2013

WASHINGTON (Reuters) - Supreme Court justices weighed on Tuesday whether makers of generic drugs already approved by the Food and Drug Administration can be held [more…]

Biogen receives patent until 2028 for Multiple Sclerosis drug Tecfidera

Biogen receives patent until 2028 for Multiple Sclerosis drug Tecfidera

Published 19/03/2013

(Reuters) - Biogen Idec Inc said on Tuesday it has been granted a new patent that will help protect the market exclusivity of its multiple [more…]

Emergency room symptoms may not predict health care needs: study

Emergency room symptoms may not predict health care needs: study

Published 19/03/2013

NEW YORK (Reuters Health) - The symptoms people come to the emergency room with may not predict the actual diagnosis they're given when they're released [more…]

Analysis: Arkansas Republicans seek an acceptable “Obamacare”

Analysis: Arkansas Republicans seek an acceptable “Obamacare”

Published 19/03/2013

WASHINGTON (Reuters) - Two Republican state senators from Arkansas may soon accomplish what seasoned Washington politicians couldn't: make the main provisions of President Barack Obama's [more…]

FDA names Kathleen Uhl acting director, office of generic drugs

FDA names Kathleen Uhl acting director, office of generic drugs

Published 19/03/2013

(Reuters) - The Food and Drug Administration has named Dr. Kathleen Uhl acting director of its Office of Generic Drugs as it initiates a nationwide [more…]

FDA staff does not recommend approval of Abbott’s heart device

FDA staff does not recommend approval of Abbott’s heart device

Published 18/03/2013

(Reuters) - Staff reviewers for the Food and Drug Administration did not recommend the approval of Abbott Laboratories' implantable heart device MitraClip, citing a lack [more…]

AstraZeneca to axe 1,600 jobs in overhaul of drug R&D

AstraZeneca to axe 1,600 jobs in overhaul of drug R&D

Published 18/03/2013

LONDON (Reuters) - AstraZeneca is to cut around 1,600 jobs as it overhauls research operations and consolidates drug development work in three major centers in [more…]

Analysis: Antibiotics crisis prompts rethink on risks, rewards

Analysis: Antibiotics crisis prompts rethink on risks, rewards

Published 18/03/2013

LONDON (Reuters) - Thirty years ago, when the world faced the terrifying prospect of an untreatable disease known as AIDS, big drugmakers scented an opportunity [more…]

Agencies warn of global TB “powder keg”, funding gap

Agencies warn of global TB “powder keg”, funding gap

Published 18/03/2013

LONDON/GENEVA (Reuters) - Deadly strains of tuberculosis that are resistant to multiple drugs are spreading around the world, and authorities urgently need another $1.6 billion [more…]

Novo Nordisk obesity drug results underwhelm investors

Novo Nordisk obesity drug results underwhelm investors

Published 18/03/2013

COPENHAGEN (Reuters) - Overweight and obese diabetes patients given high doses of Novo Nordisk's drug liraglutide achieved 6 percent weight loss in a clinical trial, [more…]